September 6, 2022 - Moderna and Pfizer Monovalent COVID-19 Vaccines No longer Authorized As Boosters
On August 31, the FDA removed emergency use authorization of the Pfizer COVID-19 monovalent vaccine and Moderna COVID-19 monovalent vaccine for individuals 12 years of age and older as booster doses, however they continue to be authorized for use as a primary vaccine series for individuals 6 months of age and older.
The Pfizer COVID-19 vaccine remains authorized as a single booster dose for individuals 5-11 years of age at least 5 months after completing a primary series of the Pfizer COVID-19 vaccine.
If you are 12 years of age or older and currently have an appointment scheduled for either the monovalent Pfizer or Moderna booster, you need to reschedule for when locations have the new COVID-19 bivalent vaccines available. Please speak with your healthcare provider.